IMMUNIC, INC. (IMUX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-07

IMMUNIC, INC. (IMUX) has filed 17 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 11 Form 8-K material event filings were reported by IMUX in the last 90 days. InsiderAlpha tracks every IMUX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About IMMUNIC, INC. (IMUX)

SEC CIK	0001280776

90-Day SEC Filing Activity

Form 4 filings (90d)	17
Form 8-K filings (90d)	11
Latest Form 4 filing	2026-07-07

Recent IMUX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-06-13	Nash Duane	Executive Chairman	P — Open-market purchase	20.0K	$0.83	$17K	SEC
2025-06-05	Neermann Joerg	Director	P — Open-market purchase	30.0K	$0.76	$23K	SEC
2025-06-05	Tardio Jason	President and COO	P — Open-market purchase	12.5K	$0.79	$10K	SEC
2025-06-04	Neermann Joerg	Director	P — Open-market purchase	70.0K	$0.77	$54K	SEC
2025-06-04	Vitt Daniel	CEO and Director	P — Open-market purchase	15.0K	$0.77	$12K	SEC
2025-06-03	Whaley Glenn	Chief Financial Officer	P — Open-market purchase	45.0K	$0.71	$32K	SEC
2025-06-03	Rudick Richard Alan	Director	P — Open-market purchase	143.1K	$0.70	$100K	SEC
2025-05-30	Whaley Glenn	Chief Financial Officer	A — Grant or award	25.0K	$0.56	$14K	SEC
2024-11-12	Rudick Richard Alan	Director	P — Open-market purchase	87.3K	$1.15	$100K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for IMMUNIC, INC. (IMUX). Updated in real time as new filings are submitted to the SEC.

Most-Active IMUX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Rudick Richard Alan	2	—
Neermann Joerg	2	—
Congleton Jon	2	—
PHILLIPS BARCLAY A	2	—
Skerjanec Simona	2	—

Recent IMUX Form 8-K Material Events

2026-07-14 — Item 7.01, 9.01 [SEC]
2026-07-06 — Item 5.02 [SEC]
2026-06-29 — Item 5.02, 5.07, 9.01 [SEC]
2026-05-28 — Item 7.01, 9.01 [SEC]
2026-05-27 — Item 5.02, 7.01, 9.01 [SEC]

Recent Insider Filings

2026-07-07 — Skerjanec Simona (Director)
2026-07-07 — Rudick Richard Alan (Director)
2026-07-07 — PHILLIPS BARCLAY A (Director)
2026-07-07 — Neermann Joerg (Director)
2026-07-07 — Congleton Jon (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in IMUX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

IMUX Insider Trading — FAQ

What is the latest insider trade for IMUX?: IMMUNIC, INC. (IMUX) had 17 insider filings in the last 90 days, with the most recent on 2026-07-07. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying IMUX stock?: 0 insider purchases of IMUX were filed in the last 90 days.
How many insiders are selling IMUX stock?: 0 insider sales of IMUX were filed in the last 90 days.
Where can I see IMUX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every IMUX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live IMUX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.